AVGR - BHC PL and ATRA are among pre market gainers
2023-09-20 08:29:58 ET
- Exscientia ( EXAI ) +30% climbs as Merck KGaA joins AI drug discovery.
- Regulus Therapeutics ( RGLS ) +16% Announces Positive Topline Data from the First Cohort of Patients in its Phase 1b Multiple-Ascending Dose Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease
- Hanryu Holdings ( HRYU ) +13% .
- Bluejay Diagnostics ( BJDX ) +12% .
- Atara Biotherapeutics ( ATRA ) +9% .
- Cemtrex ( CETX ) +10% .
- Uxin Limited ( UXIN ) +9% Announces RMB1.5 Billion Equity Investment in Its Hefei Subsidiary.
- iCoreConnect ( ICCT ) +9% .
- IN8bio ( INAB ) +7% to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference.
- Coty ( COTY ) +6% rallies after boosting full-year guidance off recent hot demand.
- Aquestive Therapeutics ( AQST ) +6% .
- Bausch Health Companies ( BHC ) +6% .
- Planet Labs ( PL ) +5% .
- Avinger ( AVGR ) +4% .
For further details see:
BHC, PL and ATRA are among pre market gainers